pharmacokinetic


Also found in: Dictionary, Thesaurus, Encyclopedia.

phar·ma·co·ki·net·ic

(far'mă-kō-ki-net'ik),
Relating to the disposition of drugs in the body (that is, their absorption, distribution, metabolism, and elimination).

pharmacokinetic

adjective Referring to pharmacokinetics, the science that studies the processes of bodily absorption, distribution, metabolism and excretion (ADME) of compounds and medicines.

phar·ma·co·ki·net·ic

(fahr'mă-kō-ki-net'ik)
Relating to the disposition of drugs in the body (i.e., their absorption, distribution, metabolism, and elimination).

phar·ma·co·ki·net·ic

(fahr'mă-kō-ki-net'ik)
Relating to disposition of drugs in body (i.e., absorption, distribution, metabolism).
References in periodicals archive ?
Results: The pharmacokinetic profiles indicated that the glucuronide conjugates of icaritin were the principle circulating metabolites and that total icaritin accounted for ~99% of prenylflavonoid exposure after administration of EWH-derived materials to rats.
Nurelin's pharmacokinetic profile is designed to reduce CNS side effects associated with immediate-release forms of amantadine, while offering potential for enhanced efficacy.
We embrace the notion that simplicity and clarity lead to good decisions by taking complex pharmacokinetic principals and making them understandable and usable for common sense drug development.
According to the known pharmacokinetic parameters of busulfan, the values for the maximum and minimum concentrations increase during the first 3 doses.
Taking 80 mg of oral ziprasidone twice daily with a meal of at least 500 kcal resulted in a mean trough level of 70 ng/mL and ensured linear pharmacokinetics.
Neuren's Phase 2a clinical trial investigated the safety, tolerability and pharmacokinetics of a 4-hour infusion of Glypromate(R) in 33 cardiac surgery patients.
In a pharmacokinetic study in marmosets (Kessler et al.
In the next section, Pharmacology, the intricate field of quinolone pharmacokinetics (PK) and pharmacodynamics (PD) is evaluated.
14) In considering whether to use HAART during the period of EPOCH therapy, we were concerned that overlapping toxicities and unpredictable pharmacokinetic interactions could lead to impaired curative potential of the EPOCH regimen.
Leading Consulting Firm is Taking Message that Pharmacokinetics is "About Time" to Key Gathering of Clinical Pharmacology and Pharmacokinetic Scientists
They emphasize how to use the pharmacokinetic equations they introduce, and the factors influencing pharmacokinetic parameters that are present in the equations.
Data Indicates Novel Sustained Release Pharmacokinetic Profile for Controlled-Release Formulation